Harmony Biosciences Holdings (HRMY) Debt Ratio (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Debt Ratio of 0.12 for Q1 2026, down 2.98% sequentially from 0.13 in Q4 2025, and down 24.97% YoY from 0.17 in Q1 2025.
Harmony Biosciences Holdings (HRMY) Debt Ratio (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Debt Ratio for 8 years, with the latest figure at 0.12 in Q1 2026.
- Quarterly Debt Ratio fell 24.97% year-over-year to 0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12 (down 24.97% YoY) and the FY2025 annual result came in at 0.13, down 28.26% from the prior year.
- Debt Ratio retreated to 0.12 in Q1 2026 per HRMY's latest filing, from 0.13 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.41 in Q1 2022 and troughed at 0.12 in Q1 2026.
- A 5-year average of 0.23 and a median of 0.22 in 2024 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio slumped 39.33% in 2022, then decreased 13.78% in 2024.
- Over 5 years, Debt Ratio stood at 0.28 in 2022, then retreated by 16.12% to 0.24 in 2023, then decreased by 24.79% to 0.18 in 2024, then fell by 28.26% to 0.13 in 2025, then slipped by 2.98% to 0.12 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.12, 0.13, and 0.14 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.11 |
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.20 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | 0.22 |
| Dec 31, 2023 | 0.24 |
| Sep 30, 2023 | 0.25 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.38 |
| Mar 31, 2022 | 0.41 |
| Dec 31, 2021 | 0.44 |
| Sep 30, 2021 | 0.49 |